Skip to main content

Board of Directors

Our board of directors has combined decades of pharma, biotech and business expertise.
Their combined strategic, financial, scientific and medical experience enhances the value we bring, by guiding us toward our shared vision to deliver safe, effective, and life-improving medicines to people living with immune-inflammatory diseases.
Leadership Board of Directors
Marc Kozin headshot
Marc Kozin
Chairman, Board of Directors
Read More
Ruti Alon headshot
Ruth Alon, M.B.A.
Director
Read More
Shmuel (Muli) Ben Zvi, Ph.D. headshot
Shmuel (Muli) Ben Zvi, Ph.D.
Director
Read More
Dror Harats headshot
Prof. Dror Harats, M.D.
Director
Read More
David Hastings headshot
David Hastings
Director
Read More
Michael Rice headshot
Michael Rice
Director
Read More
Shmuel (Muli) Ben Zvi, Ph.D. headshot

Shmuel (Muli) Ben Zvi, Ph.D.

Director

Shmuel (Muli) Ben Zvi, Ph.D. has served on our board of directors since September 2018. Dr. Ben Zvi is currently a board member at Bank Leumi, the second largest bank in Israel, and a member of its credit, technology and strategy committees. Dr. Ben Zvi is also a board member of SOL-GEL Technologies (Nasdaq: SLGL) and a member of the audit and compensation committees. From 2004 to 2014, Dr. Ben Zvi held various managerial positions at Teva Pharmaceuticals Industries Ltd., dual listed on Nasdaq and the TASE, including as vice president of finance and vice president of strategy. From 2000 to 2004, Dr. Ben Zvi was the financial advisor to the chief of general staff of the Israel Defense Forces and head of the Defense Ministry budget department.

Dr. Ben Zvi holds a Ph.D. in economics from Tel-Aviv University, Israel and participated in the Harvard Business School Advanced Management Program (AMP).